美国放射学会适宜性标准®:胰腺导管腺癌的分期
美国放射学会基于证据制定胰腺导管腺癌分期影像检查适宜性标准,采用RAND/UCLA适宜性方法与GRADE评级。推荐多期增强多排CT和MRI作为治疗前分期与可切除性评估的首选影像,超声内镜用于活检引导,氟-18-2-氟-2-脱氧-D-葡萄糖PET/CT用于确认远处转移。
要点
- 多期增强多排CT和MRI是胰腺导管腺癌治疗前分期和术前可切除性判断的首选影像方法。
- 报告需包含肿瘤大小、位置及与特定血管的受累程度等关键发现,而不仅是有无远处转移。
- 超声内镜用于特定场景的活检引导,氟-18-2-氟-2-脱氧-D-葡萄糖PET/CT用于确认远处转移。
核心结论
- 多期增强多排CT和MRI是胰腺导管腺癌治疗前分期和术前可切除性判断的首选影像方法,超声内镜和氟-18-2-氟-2-脱氧-D-葡萄糖PET/CT分别用于活检引导和确认远处转移等特定场景。
研究设计与样本
- 美国放射学会适宜性标准由多学科专家小组每年审查,制定与修订包括对同行评议期刊当前医学文献的广泛分析,并应用RAND/UCLA适宜性方法和GRADE对特定临床场景的影像与治疗程序适宜性进行评级;证据缺乏或模棱两可时,专家意见可补充现有证据。
诊断标准与关键数值
- 多期增强多排CT和MRI被列为治疗前分期和术前可切除性判断的首选影像方法。
- 超声内镜适用于活检引导等特定场景。
- 氟-18-2-氟-2-脱氧-D-葡萄糖PET/CT适用于确认远处转移等特定场景。
临床应用与阅片要点
- 报告除有无远处转移外,还需报告肿瘤大小、位置及与潜在神经周围肿瘤播散相关的特定血管受累程度等关键发现。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Pancreatic adenocarcinoma is associated with poor overall prognosis. Complete surgical resection is the only possible option for cure. As such, increasingly complex surgical techniques including sophisticated vascular reconstruction are being used. Continued advances in surgical techniques, in conjunction with use of combination systemic therapies, and radiation therapy have been suggested to improve outcomes. A key aspect to surgical success is reporting of pivotal findings beyond absence of distant metastases, such as tumor size, location, and degree of tumor involvement of specific vessels associated with potential perineural tumor spread. Multiphase contrast-enhanced multidetector CT and MRI are the imaging modalities of choice for pretreatment staging and presurgical determination of resectability. Imaging modalities such as endoscopic ultrasound and fluorine-18-2-fluoro-2-deoxy-D-glucose imaging with PET/CT are indicated for specific scenarios such as biopsy guidance and confirmation of distant metastases, respectively. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.
引用
- Qayyum A, Tamm EP, Kamel IR, et al. ACR Appropriateness Criteria® Staging of Pancreatic Ductal Adenocarcinoma. J Am Coll Radiol. 2017. PMID: 29101993. doi:10.1016/j.jacr.2017.08.050
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。